Is it safe to use GLP-1 receptor agonists in a patient with a history of thyroid nodules and a family history of thyroid cancer with unknown pathology?
Abstract
Current evidence indicates caution due to potential thyroid cancer risks with GLP-1 receptor agonists, especially in familial medullary thyroid cancer contexts, but lacks definitive guidance for histories of thyroid nodules or unspecified thyroid cancer in family history.
Fields of Study & Subjects
Thyroid Cancer Diagnosis and Treatment
Diabetes Treatment and Management
Thyroid Disorders and Treatments
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 29 January 2026